` MARKSANS (Marksans Pharma Ltd) vs BSE Sensex 30 Comparison - Alpha Spread

MARKSANS
vs
BSE Sensex 30

Over the past 12 months, MARKSANS has outperformed BSE Sensex 30, delivering a return of 25% compared to the BSE Sensex 30's 6% growth.

Stocks Performance
MARKSANS vs BSE Sensex 30

Loading

Performance Gap
MARKSANS vs BSE Sensex 30

Loading
MARKSANS
BSE Sensex 30
Difference

Performance By Year
MARKSANS vs BSE Sensex 30

Loading
MARKSANS
BSE Sensex 30
Add Stock

Competitors Performance
Marksans Pharma Ltd vs Peers

BSE Sensex 30
MARKSANS
LLY
JNJ
NOVO B
ROG
Add Stock

Marksans Pharma Ltd
Glance View

Economic Moat
Narrow
Market Cap
96.8B INR
Industry
Pharmaceuticals

Marksans Pharma Ltd. is a prominent player in the global pharmaceutical landscape, with its roots deeply embedded in the meticulous world of drug formulation and manufacturing. The company weaves its narrative through a robust portfolio that spans various therapeutic segments, including pain management, oncology, cardiovascular health, and anti-diabetic medications. By navigating the complexities of regulated markets such as the United States, the United Kingdom, and Australia, Marksans has engineered a business model that emphasizes quality, compliance, and innovation. This framework allows the company not only to design and develop a diverse array of generic pharmaceutical products but also to efficiently cater to a global clientele through its cost-effective yet high-quality manufacturing processes. Central to Marksans' success is its strategic integration of research and development with flexible manufacturing capabilities, housed in state-of-the-art facilities across Goa and India. These facilities, certified by leading international regulatory bodies, enable Marksans to maintain a competitive edge in both product delivery and diversification. By leveraging strategic partnerships and continuously expanding its product portfolio, it thrives in the dynamic pharmaceutical market. Revenue generation flows seamlessly through its vertically integrated operations, which streamline the journey from drug conception to distribution. Through these concerted efforts, Marksans not only bolsters its financial standing but also contributes significantly to the broader field of global healthcare, aligning economic performance with a commitment to health and well-being.

MARKSANS Intrinsic Value
202.07 INR
Overvaluation 5%
Intrinsic Value
Price
Back to Top